Search Results - "Mikami, Tadayoshi"
-
1
Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain
Published in European journal of pharmacology (31-03-2008)“…We sought to examine the involvement of central cannabinoid CB2 receptor activation in modulating mechanical allodynia in a mouse model of neuropathic pain…”
Get full text
Journal Article -
2
5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs
Published in The Journal of pharmacology and experimental therapeutics (01-04-2008)“…5-Hydroxytryptamine (5-HT) receptors and dopamine(2) (D(2)) receptor modulate gastrointestinal motility. Gastroprokinetic agents that act on several 5-HT…”
Get more information
Journal Article -
3
Contribution of Active and Inactive States of the Human 5-HT4d Receptor to the Functional Activities of 5-HT4–Receptor Agonists
Published in Journal of Pharmacological Sciences (2008)“…In the present study, binding affinities of 5-hydroxytryptamine-4 (5-HT4) ligands for the human 5-HT4d receptor were determined using the agonist [3H]5-HT and…”
Get full text
Journal Article -
4
Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse
Published in European journal of pharmaceutical sciences (2001)“…We investigated neurochemically and neuropathologically the utility of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice as a model of…”
Get full text
Journal Article -
5
Pharmacological and clinical profile of inclisiran sodium, a long-acting LDL cholesterol lowering siRNA, LEQVIO for s.c. injection syringe 300 mg
Published in Nihon yakurigaku zasshi (01-07-2024)“…Inclisiran sodium (Brand name: LEQVIO for s.c. injection syringe 300 mg, hereinafter referred to as inclisiran), a small interfering ribonucleic acid (siRNA)…”
Get more information
Journal Article -
6
T+31C polymorphism of angiotensinogen gene and nocturnal blood pressure decline: the Ohasama study
Published in American journal of hypertension (01-07-2002)“…We assessed the association between several polymorphisms of angiotensinogen gene ( AGT) and essential hypertension using ambulatory blood pressure (BP). We…”
Get full text
Journal Article -
7
Involvement of central cannabinoid CB 2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain
Published in European journal of pharmacology (2008)“…We sought to examine the involvement of central cannabinoid CB 2 receptor activation in modulating mechanical allodynia in a mouse model of neuropathic pain…”
Get full text
Journal Article -
8
In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT4 receptor
Published in European journal of pharmacology (01-05-2009)Get full text
Journal Article -
9
-
10
In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT 4 receptor
Published in European journal of pharmacology (2009)“…The pharmacological profile of PF-01354082, a selective 5-HT 4 receptor partial agonist, was investigated. PF-01354082 displayed high affinity for human 5-HT…”
Get full text
Journal Article -
11
Pharmacological characterization and determination of pharmacokinetic and pharmacodynamic relationship of PF-00885706, a novel partial agonist selective for the 5-HT 4 receptor
Published in Pharmacological research (2009)“…The pharmacological profile of PF-00885706, a selective 5-HT 4 receptor partial agonist, was investigated. PF-00885706 displayed a high binding affinity for…”
Get full text
Journal Article -
12
Pharmacological characterization and determination of pharmacokinetic and pharmacodynamic relationship of PF-00885706, a novel partial agonist selective for the 5-HT(4) receptor
Published in Pharmacological research (01-10-2009)“…The pharmacological profile of PF-00885706, a selective 5-HT(4) receptor partial agonist, was investigated. PF-00885706 displayed a high binding affinity for…”
Get full text
Journal Article -
13
In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor
Published in European journal of pharmacology (01-05-2009)“…The pharmacological profile of PF-01354082, a selective 5-HT(4) receptor partial agonist, was investigated. PF-01354082 displayed high affinity for human…”
Get full text
Journal Article -
14
P-148: Genetic involvement of T+31C polymorphism in angiotensinogen gene for daytime and nighttime blood pressure: The O study
Published in American journal of hypertension (01-04-2001)“…Objectives: The polymorphisms of human angiotensinogen gene were reported as genetic predisposing factors for cardiovascular disease. We recently documented…”
Get full text
Journal Article -
15
Genetic involvement of T+31C polymorphism in angiotensinogen gene for daytime and nighttime blood pressure: the O study
Published in American journal of hypertension (01-11-2001)Get full text
Journal Article